Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Isotechnika gets Chinese nod for Helicobacter pylori kit:

This article was originally published in Clinica

Executive Summary

Canada's Isotechnika has received approval in China to sell its Helikit, a noninvasive, non-radioactive breath test kit for Helicobacter pylori. The Edmonton, Alberta firm says it now holds two licences for the importation of the Helikit into China, with additional licences held in Canada, Hong Kong, Korea, Mexico and Taiwan. It has also secured a Taiwan-based distributor for Taiwan, China, and Hong Kong, called Success Vision Biotek. As part of the agreement, the distributor will purchase a minimum of 180,000 kits over a three-year period. An order for 12 Isomax point-of-care analysers for use with the Helikit has also been placed and is expected to be filled by the end of the year, Isotechnika adds.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057482

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel